PROCHLORPERAZINE EDISYLATE Drug Patent Profile
✉ Email this page to a colleague
When do Prochlorperazine Edisylate patents expire, and what generic alternatives are available?
Prochlorperazine Edisylate is a drug marketed by Morton Grove, Amneal, Avet Lifesciences, Caplin, Eugia Pharma, Gland Pharma Ltd, Hikma, Hospira, Marsam Pharms Llc, Mylan Labs Ltd, Nexus, Sagent, Smith And Nephew, Teva Parenteral, Viwit Pharm, Watson Labs, Wyeth Ayerst, and Alpharma Us Pharms. and is included in twenty-three NDAs.
The generic ingredient in PROCHLORPERAZINE EDISYLATE is prochlorperazine edisylate. There are twenty-one drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the prochlorperazine edisylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prochlorperazine Edisylate
A generic version of PROCHLORPERAZINE EDISYLATE was approved as prochlorperazine edisylate by HIKMA on August 29th, 1989.
Summary for PROCHLORPERAZINE EDISYLATE
| US Patents: | 0 |
| Applicants: | 18 |
| NDAs: | 23 |
| Finished Product Suppliers / Packagers: | 16 |
| Raw Ingredient (Bulk) Api Vendors: | 35 |
| Patent Applications: | 348 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PROCHLORPERAZINE EDISYLATE at DailyMed |
Pharmacology for PROCHLORPERAZINE EDISYLATE
| Drug Class | Phenothiazine |
Anatomical Therapeutic Chemical (ATC) Classes for PROCHLORPERAZINE EDISYLATE
US Patents and Regulatory Information for PROCHLORPERAZINE EDISYLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morton Grove | PROCHLORPERAZINE EDISYLATE | prochlorperazine edisylate | CONCENTRATE;ORAL | 088598-001 | Oct 25, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Watson Labs | PROCHLORPERAZINE EDISYLATE | prochlorperazine edisylate | INJECTABLE;INJECTION | 089530-001 | Jul 8, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hikma | PROCHLORPERAZINE EDISYLATE | prochlorperazine edisylate | INJECTABLE;INJECTION | 089523-001 | May 3, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Caplin | PROCHLORPERAZINE EDISYLATE | prochlorperazine edisylate | INJECTABLE;INJECTION | 214379-001 | Apr 22, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Mylan Labs Ltd | PROCHLORPERAZINE EDISYLATE | prochlorperazine edisylate | INJECTABLE;INJECTION | 210710-001 | Oct 25, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
